Literature DB >> 3348836

Inhibitory effect of calcium antagonists on balloon catheter-induced arterial smooth muscle cell proliferation and lesion size.

C L Jackson1, R C Bush, D E Bowyer.   

Abstract

Calcium antagonists inhibit atherogenesis in the cholesterol-fed rabbit without producing hypolipidaemia, suggesting a direct action on the arterial wall. In this study, the effects of several calcium antagonists on the myoproliferative response to balloon catheter injury of the aorta have been investigated in normolipidaemic rats and rabbits. The incorporation of [3H]thymidine into rat aortic DNA 48 h after balloon injury was markedly reduced by twice daily oral administration of nifedipine, verapamil, diltiazem or lanthanum. DNA synthesis in other proliferating tissues was unaffected. Twice daily oral administration of prazosin or minoxidil, antihypertensive agents that are not calcium antagonists, also selectively reduced arterial DNA synthesis. In balloon catheterised rabbits twice daily oral administration of nifedipine (10 mg/kg) caused a 39% reduction in the cross-sectional area of the neo-intima 14 days after injury. These results show that nifedipine and other antihypertensive agents inhibit smooth muscle cell proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3348836     DOI: 10.1016/0021-9150(88)90004-4

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

Review 1.  Antiatherogenic effects of calcium-channel blockers: possible mechanisms of action.

Authors:  P D Henry
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

2.  Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).

Authors:  P R Lichtlen; P G Hugenholtz; W Rafflenbeul; H Hecker; S Jost; P Nikutta; J W Deckers
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

Review 3.  Influence of nifedipine on experimental arteriosclerosis.

Authors:  A M Knorr; S Kazda
Journal:  Cardiovasc Drugs Ther       Date:  1990-08       Impact factor: 3.727

4.  Calcium-channel blockers inhibit human low-density lipoprotein oxidation by oxygen radicals.

Authors:  C Napoli; M Chiariello; G Palumbo; G Ambrosio
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

5.  Effect of Anti-Hypertensive Medication History on Arteriovenous Fistula Maturation Outcomes.

Authors:  Ke Wang; Leila R Zelnick; Peter B Imrey; Ian H deBoer; Jonathan Himmelfarb; Michael D Allon; Alfred K Cheung; Laura M Dember; Prabir Roy-Chaudhury; Miguel A Vazquez; John W Kusek; Harold I Feldman; Gerald J Beck; Bryan Kestenbaum
Journal:  Am J Nephrol       Date:  2018-08-02       Impact factor: 3.754

6.  Carvedilol, a cardiovascular drug, prevents vascular smooth muscle cell proliferation, migration, and neointimal formation following vascular injury.

Authors:  E H Ohlstein; S A Douglas; C P Sung; T L Yue; C Louden; A Arleth; G Poste; R R Ruffolo; G Z Feuerstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

7.  Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.

Authors:  M N el-Sanadiki; K S Cross; J J Murray; R W Schuman; E Mikat; R L McCann; P O Hagen
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

8.  Effect of verapamil on intimal thickening and vascular reactivity in the collared carotid artery of the rabbit.

Authors:  L Ustünes; M Yasa; Z Kerry; N Ozdemir; T Berkan; Y Erhan; A Ozer
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

9.  Inhibitory effect of clentiazem (TA-3090), a new calcium antagonist, on balloon catheter-induced intimal thickening of rabbit aorta.

Authors:  Y Saso; A Ohtani; A Odawara; H Iwasaki; K Takashima; T Morita
Journal:  Cardiovasc Drugs Ther       Date:  1993-04       Impact factor: 3.727

10.  Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis.

Authors:  E Hoberg; R Dietz; U Frees; H A Katus; B Rauch; A Schömig; G Schuler; F Schwarz; H Tillmanns; J Niebauer
Journal:  Br Heart J       Date:  1994-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.